ATE341337T1 - P-selectin zeilgerichtetenligand und dessen zusammenstezung - Google Patents

P-selectin zeilgerichtetenligand und dessen zusammenstezung

Info

Publication number
ATE341337T1
ATE341337T1 AT04735558T AT04735558T ATE341337T1 AT E341337 T1 ATE341337 T1 AT E341337T1 AT 04735558 T AT04735558 T AT 04735558T AT 04735558 T AT04735558 T AT 04735558T AT E341337 T1 ATE341337 T1 AT E341337T1
Authority
AT
Austria
Prior art keywords
alkyl
group
optionally substituted
moiety
selectin
Prior art date
Application number
AT04735558T
Other languages
English (en)
Inventor
Chantal C M Appeldoorn
Berkel Theodorus Josephus Van
Erik Anna Leonardus Biessen
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE341337T1 publication Critical patent/ATE341337T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT04735558T 2003-05-30 2004-06-01 P-selectin zeilgerichtetenligand und dessen zusammenstezung ATE341337T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20030012123 EP1481683A1 (de) 2003-05-30 2003-05-30 P-Selectin Zeilgerichtetenligand und dessen Zusammenstezung

Publications (1)

Publication Number Publication Date
ATE341337T1 true ATE341337T1 (de) 2006-10-15

Family

ID=33104110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04735558T ATE341337T1 (de) 2003-05-30 2004-06-01 P-selectin zeilgerichtetenligand und dessen zusammenstezung

Country Status (8)

Country Link
US (1) US8003596B2 (de)
EP (2) EP1481683A1 (de)
JP (1) JP4771291B2 (de)
AT (1) ATE341337T1 (de)
CA (1) CA2527438A1 (de)
DE (1) DE602004002699T2 (de)
ES (1) ES2273260T3 (de)
WO (1) WO2004105783A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2467759C2 (ru) 2006-11-15 2012-11-27 Артрайтис Рилиф Плас Лтд Состав для местного использования и его применения
WO2008089771A1 (en) * 2007-01-24 2008-07-31 Syddansk Universitet Dna controlled assembly of lipid membranes
TR201908314T4 (tr) * 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
JP2016160248A (ja) * 2015-03-05 2016-09-05 国立大学法人京都大学 糖誘導体、またはその塩、セレクチン結合剤、糖結合体、粒子状キャリア、および輸送方法
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
EP4326743A1 (de) * 2021-04-20 2024-02-28 BicycleTX Limited Für p-selectin spezifische bicyclische peptidliganden
CN113616810A (zh) * 2021-08-11 2021-11-09 南开大学 一种靶向p-选择素的工程化细胞外囊泡组合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052858A2 (en) 1998-04-08 1999-10-21 Celltech Therapeutics Limited Lipids
GB9919338D0 (en) * 1999-08-16 1999-10-20 Celltech Therapeutics Ltd Biological products
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
EP1337278A2 (de) 2000-11-27 2003-08-27 Bristol-Myers Squibb Medical Imaging, Inc. Gleichzeitiges imaging der kardialen perfusion und eines auf den vitronektin rezeptor zielgerichteten agens
PL369455A1 (en) 2001-06-01 2005-04-18 Yamanouchi Europe B.V. Lipid-polymer-conjugates
EP1288222A1 (de) 2001-09-03 2003-03-05 Yamanouchi Europe B.V. Selektiv P-Selectin bindende peptidische Verbindungen

Also Published As

Publication number Publication date
EP1638588A1 (de) 2006-03-29
CA2527438A1 (en) 2004-12-09
EP1481683A1 (de) 2004-12-01
US8003596B2 (en) 2011-08-23
EP1638588B1 (de) 2006-10-04
JP4771291B2 (ja) 2011-09-14
WO2004105783A1 (en) 2004-12-09
JP2007500200A (ja) 2007-01-11
DE602004002699D1 (de) 2006-11-16
DE602004002699T2 (de) 2007-08-16
US20070185348A1 (en) 2007-08-09
ES2273260T3 (es) 2007-05-01

Similar Documents

Publication Publication Date Title
Zhang et al. Dynamic covalent polymers for biomedical applications
Thornton et al. Enzyme‐responsive polymer hydrogel particles for controlled release
KR101895245B1 (ko) 양친매성 선형 펩티드/펩토이드 및 이를 포함하는 히드로겔
WO2006001382A1 (ja) ジペプチドまたはジペプチド誘導体の製造法
Kabiri et al. Toward a mechanistic understanding of ionic self-complementary peptide self-assembly: role of water molecules and ions
JPWO2009005151A1 (ja) 新規脂質ペプチド並びにヒドロゲル
MX2011005528A (es) Metodo para producir derivados funcionalizados con acido hialuronico y formacion de sus hidrogeles.
ATE341337T1 (de) P-selectin zeilgerichtetenligand und dessen zusammenstezung
RU2007103811A (ru) Пептидные антибиотики и способы их получения
CN105102469A (zh) 交联的肽水凝胶
JPWO2007000979A1 (ja) 自己組織化ペプチドおよびそれより得られるゲル
CA2368824A1 (en) Rapid dehydration of proteins
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
Beyer et al. Low fouling peptides with an all (D) amino acid sequence provide enhanced stability against proteolytic degradation while maintaining low antifouling properties
Morton et al. Crosslinker structure modulates bulk mechanical properties and dictates hMSC behavior on hyaluronic acid hydrogels
FR3032202A1 (fr) Matrice sous forme de bille comme support cellulaire
Mertz et al. Ultrathin, bioresponsive and drug-functionalized protein capsules
FR2992318A1 (fr) Materiaux hybrides peptide-silice
US7829337B2 (en) Cell-releasing agent and method of releasing cell sheet
Miura et al. In vitro selection of macrocyclic l-α/d-α/β/γ-hybrid peptides targeting IFN-γ/IFNGR1 protein–protein interaction
Knoth et al. The Ras pathway modulator melophlin A targets dynamins
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
Bernhard et al. Spectrophotometric and structural evidence as to the mechanism of protease catalysis at chemical bonding resolution
RU2184114C2 (ru) Новые производные бензоксазиндиона и лекарственный препарат на их основе
US20220325072A1 (en) Zwitterionic crosslinkers, hydrogels comprising zwitterionic crosslinkers, and methods for making and using

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties